Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development Meeting Abstract
| Authors: | Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; Jhaveri, K. L.; Harding, J. J.; Gounder, M. M.; Rosen, E.; Rosen, N.; Misale, S.; Lito, P.; Yaeger, R.; Drilon, A. E.; Li, B. T. |
| Abstract Title: | Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301029 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3135 |
| Notes: | Meeting Abstract: 3135 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
